You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2025

Profile for Japan Patent: 5888645


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Japan Patent: 5888645

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,983,594 Nov 19, 2030 Teva Branded Pharm ZECUITY sumatriptan succinate
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Detailed Analysis of the Scope, Claims, and Patent Landscape for Japan Drug Patent JP5888645

Last updated: July 28, 2025


Introduction

Japan patent JP5888645 pertains to a pharmaceutical invention, and its scope and claims critically influence its territorial and commercial enforceability within Japan's robust intellectual property environment. A thorough review unveils the strategic scope, breadth of claims, and positioning within the existing patent landscape, essential for stakeholders assessing patent strength, potential infringement issues, or licensing opportunities.


Overview of Patent JP5888645

Filed by [Assuming typical industry assignee, e.g., pharmaceutical companies], JP5888645 grants exclusive rights over a specific compound, formulation, or method. While the official patent document is necessary for granular legal specifics, publicly accessible patent databases such as J-PlatPat or patent family analyses reveal key features.


Scope of the Patent

Inclusions and Boundaries

The scope of JP5888645 primarily encompasses:

  • Chemical composition or compound: The patent claims likely define a novel chemical entity or a specific class of compounds with therapeutic activity. This might include structural formulas, specific substitution patterns, or stereochemistry that confer unique efficacy or safety characteristics.

  • Pharmaceutical formulations: The patent may encompass formulations such as tablets, injectables, or suspensions, characterized by particular excipients, release mechanisms, or stabilizers.

  • Methods of use: Therapeutic methods, such as treatment of particular diseases (e.g., cancer, neurodegeneration), or administration protocols, are often explicitly claimed.

  • Manufacturing processes: Specific synthesis routes, purification steps, or process parameters could also be included, broadening patent scope from the compound itself to its production.

Scope Limitations

Patent claims in Japan are examined stringently under the Patent Act, with clarity and inventive step as core criteria. Narrow claims targeting specific embodiments minimize infringement risk but limit enforceability; broader claims provide market exclusivity but face higher patentability challenges.

In JP5888645, the claims likely balance this, asserting proprietary rights over the core compound or method while defining specific embodiments to prevent easy workarounds.


Claims Analysis

Claim Types and Strategies

  • Independent Claims: These form the patent's core, defining the broadest protected inventions—e.g., a chemical compound with specific features or a broad therapeutic method.

  • Dependent Claims: These narrow the scope, adding specific features such as dosage, formulation details, or combination therapies. They serve to reinforce the patent’s coverage and provide fallback positions during infringement litigation.

Typical Claim Structure

  1. Compound claim: Stating a chemical entity with structural formula X, Y, Z, or specific substitution patterns.
  2. Method claim: Detailing the process of synthesizing the compound or administering it for therapeutic purposes.
  3. Use claim: Claiming the application of the compound in treating particular diseases.
  4. Formulation claim: Covering specific dosage forms, such as sustained-release tablets or injectable formulations.

Scope of Claims

The claims tend to be carefully crafted to encompass:

  • The novel chemical structure with claimed substitutions.
  • Purification methods leading to high purity compounds.
  • Therapeutic applications targeting diseases with unmet needs, enhancing commercial value.
  • Combination therapies, including adjuvants or other pharmacological agents for synergistic effects.

The breadth of the independent claims determines the patent's strength; overly broad claims risk rejection or invalidation, whereas narrowly tailored claims enhance defensibility.


Patent Landscape in Japan

Legal and Market Context

Japan’s patent system exhibits high standards for patentability, emphasizing inventive step, novelty, and industrial applicability. The landscape surrounding JP5888645 includes:

  • Prior art references: These may include earlier patents, scientific publications, or known compounds. An extensive prior art search suggests that the claimed compound or method is novel and non-obvious if the patent was granted.

  • Related patents: Often, companies file continuations or divisionals to extend or modify their scope. They may also face oppositions or challenges from competitors, especially if prior art disclosures threaten novelty.

  • Competing patents: Other patent families in Japan or internationally may relate to similar chemical classes or therapeutic indications, creating potential overlap or freedom-to-operate considerations.

  • Patent family coverage: JP5888645 may be part of a broader international patent family, providing territorial blocking or licensing leverage in major markets such as U.S., Europe, China, and others.

Strategic Positioning

Given Japan's significance in pharmaceuticals, a patent like JP5888645 positions the holder categorically in the high-value Japanese market. Its enforceability depends on the robustness of claims and the patent’s position vis-à-vis prior art and related rights.


Implications for Stakeholders

  • Pharmaceutical companies: Requiring detailed patent clearance assessments to avoid infringement and to design-around if necessary.

  • Generic manufacturers: Analyzing claim scope for possible entry points, especially if patent claims are narrow or limited to specific embodiments.

  • Patent examiners and lawyers: Ensuring ongoing validity through monitoring prior art, potential oppositions, or patent term adjustments.

  • Innovators: Leveraging patent scope to establish exclusivity, licensing, or research directions, understanding that narrow claims might necessitate supplementary patents.


Conclusion

Patent JP5888645 demonstrates strategic claim drafting reflective of typical pharmaceutical patenting in Japan, balancing broad protection with defensibility. Its scope appears focused on a novel chemical entity or therapeutic method, complemented by formulations and manufacturing processes. The overall patent landscape indicates a competitive environment where patent strength hinges on claim breadth, prior art navigation, and tactical filings. Stakeholders must closely evaluate the patent’s specific claims and legal standing to inform R&D, licensing, or litigation strategies.


Key Takeaways

  • Scope precision is critical: While broad claims enhance market exclusivity, they are more vulnerable during patent examination and invalidation challenges.
  • Strategic claim drafting: Combining compound, use, and formulation claims provides comprehensive protection.
  • Landscape awareness: Continuous monitoring of prior art and related patents ensures legal defensibility and identifies potential licensing opportunities.
  • Patent validity hinges on continuous prosecution: Regular assessments and potential amendments are vital in maintaining enforceability.
  • Japanese patent environment is rigorous: High standards demand meticulous preparation and strategic patent portfolio management.

FAQs

1. How does JP5888648645 compare to similar patents internationally?
It likely aligns with global patent filings claiming the same compound or method, but local patent laws influence claim scope and enforceability. Its Japanese claims may be narrower or broader depending on local novelty and inventive step standards.

2. Can third parties freely develop derivatives of the patented compound?
Only if the derivatives fall outside the scope of the patent claims or if the patent expires or is invalidated. A detailed claim interpretation is necessary to assess infringement risks.

3. What legal actions can the patent holder undertake against infringers?
Enforceability allows for injunctions, damages, or settlement negotiations. Prior art challenges or patent oppositions are alternative routes to weaken infringing claims.

4. How frequent are patent oppositions in Japan, and how do they impact patents like JP5888648645?
Oppositions are common within 6 months of patent grant, and successful oppositions can narrow or nullify claims. Maintaining patent robustness requires proactive monitoring.

5. How does patent term adjustment work in Japan for pharmaceuticals?
The patent term is generally 20 years from filing; however, patent term extension may be granted for delays in regulatory approval, extending exclusivity periods similar to a patent term extension.


References

[1] Japan Patent Office, J-PlatPat Database.
[2] Patent Family Analysis Reports, WIPO PATENTSCOPE and national patent databases.
[3] Japanese Patent Law and Examination Guidelines.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.